Osaka, Japan

Koshiro Goda


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1985-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Koshiro Goda: Innovator in Beta-Lactam Compounds

Introduction

Koshiro Goda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactam compounds. With a total of 3 patents to his name, Goda's work has been instrumental in advancing medicinal chemistry.

Latest Patents

Goda's latest patents focus on beta-lactams and their production. One of his notable inventions is a beta-lactam compound characterized by a specific formula, where R₁ and R₂ can be hydrogen or lower alkyl groups, and R₃⁰ is a lower alkyl group with a beta-configuration. This compound serves as a valuable intermediate in the stereospecific production of 1-alkylcarbapenem compounds. Another patent also revolves around a similar beta-lactam compound, emphasizing its utility in pharmaceutical applications.

Career Highlights

Throughout his career, Koshiro Goda has worked with reputable companies such as Sumitomo Pharmaceuticals Company Limited and Sumitomo Chemical Company, Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in the industry.

Collaborations

Goda has collaborated with notable colleagues, including Makoto Sunagawa and Akira Sasaki. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field of medicinal chemistry.

Conclusion

Koshiro Goda's contributions to the development of beta-lactam compounds highlight his role as a key innovator in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…